Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy

PLoS ONE

DOI: 10.1371/journal.pone.0202549 Full text (OA) OpenAlex

Authors 0

Author list not loaded yet.

Cited by 14 stored of 45

Longitudinal polarization diversity optical coherence tomography before and after photodynamic therapy in chronic central serous chorioretinopathy: a prospective clinical study
2026 International Journal of Retina and Vitreous article Medicine Retinal Diseases and Treatments Open access

0

citations
Long‐term follow‐up of chronic central serous chorioretinopathy patients receiving oral eplerenone and half‐dose photodynamic therapy in the SPECTRA trial: SPECTRA trial report No. 4
2026 Acta Ophthalmologica article Medicine Retinal Diseases and Treatments Open access

0

citations
Exploring retinal and choroidal characteristics on multimodal imaging in resolved central serous chorioretinopathy
2026 Eye article Medicine Retinal Diseases and Treatments Open access

0

citations
Analysis of optical coherence tomography biomarker probability detection in central serous chorioretinopathy by using an artificial intelligence-based biomarker detector
2024 International Journal of Retina and Vitreous article Medicine Retinal Diseases and Treatments Open access

8

citations
Choroidal hyperpermeability patterns correlate with disease severity in central serous chorioretinopathy: CERTAIN study report 2
2024 Acta Ophthalmologica article Medicine Retinal Diseases and Treatments Open access

14

citations
Central serous chorioretinopathy: An evidence-based treatment guideline
2024 Progress in Retinal and Eye Research article Medicine Retinal Diseases and Treatments Open access

129

citations
BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC RETINAL LAYER FEATURES IDENTIFIED BY ARTIFICIAL INTELLIGENCE PREDICT THE COURSE OF CENTRAL SEROUS CHORIORETINOPATHY
2023 Retina article Medicine Retinal Diseases and Treatments Open access

17

citations
INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
2023 Retina article Medicine Retinal Diseases and Treatments Open access

24

citations
Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled Trial
2021 American Journal of Ophthalmology article Medicine Retinal Diseases and Treatments Open access

101

citations
Long‐term follow‐up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser
2021 Acta Ophthalmologica article Medicine Retinal Diseases and Treatments Open access

37

citations
Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy
2020 Graefe s Archive for Clinical and Experimental Ophthalmology article Medicine Retinal Diseases and Treatments Open access

10

citations
Central serous chorioretinopathy: An update on risk factors, pathophysiology and imaging modalities
2020 Progress in Retinal and Eye Research article Medicine Retinal Diseases and Treatments Open access

253

citations
Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial
2020 American Journal of Ophthalmology article Medicine Retinal Diseases and Treatments Open access

53

citations
Reply to Comment on: Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3
2020 American Journal of Ophthalmology letter Medicine Retinal Diseases and Treatments

11

citations

14 results

Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy

Authors 0

Cited by 14 stored of 45

References 0